Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy
Michael C. Johnston, Christopher J. Scott
Drug Discovery Today Technologies (2018) Vol. 30, pp. 63-69
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy
Aniket Wahane, Akaash Waghmode, Alexander Kapphahn, et al.
Molecules (2020) Vol. 25, Iss. 12, pp. 2866-2866
Open Access | Times Cited: 167
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 66
Delivering on the promise of protein degraders
Matthew N. O’Brien, Suman Luthra, Matthew F. Brown, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 410-427
Closed Access | Times Cited: 55
Antibody-Drug Conjugates: A promising breakthrough in cancer therapy
Swapnali Parit, Ajit Manchare, Amol D. Gholap, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124211-124211
Closed Access | Times Cited: 16
Nanoparticle innovations in targeted cancer therapy: advancements in antibody–drug conjugates
Magdi T. Abdelhamid, Al-Hassan Soliman Wadan, Hosam A. Saad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 3
Emerging Nanoparticle-Based Diagnostics and Therapeutics for Cancer: Innovations and Challenges
Rachitha Puttasiddaiah, Nagaraj Basavegowda, Nityashree Kyathegowdanadoddi Lakshmanagowda, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 70-70
Open Access | Times Cited: 2
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
Sara Ponziani, Giulia Di Vittorio, Giuseppina Pitari, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5510-5510
Open Access | Times Cited: 129
Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer
Jiahui Peng, Juan Chen, Fang Xie, et al.
Biomaterials (2019) Vol. 222, pp. 119420-119420
Closed Access | Times Cited: 98
PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems
Diego Romano Perinelli, Marco Cespi, Giulia Bonacucina, et al.
Journal of Pharmaceutical Investigation (2019) Vol. 49, Iss. 4, pp. 443-458
Closed Access | Times Cited: 92
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
Alberto Juan, Francisco J. Cimas, Iván Bravo, et al.
Pharmaceutics (2020) Vol. 12, Iss. 9, pp. 802-802
Open Access | Times Cited: 89
Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates
Alberto Dal Corso, Luca Pignataro, Laura Belvisi, et al.
Chemistry - A European Journal (2019) Vol. 25, Iss. 65, pp. 14740-14757
Open Access | Times Cited: 87
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
Alberto Juan, Francisco J. Cimas, Iván Bravo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6018-6018
Open Access | Times Cited: 83
A quantitative view on multivalent nanomedicine targeting
Laura Woythe, Nicholas B. Tito, Lorenzo Albertazzi
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 1-21
Open Access | Times Cited: 74
Antibody‐Incorporated Nanomedicines for Cancer Therapy
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen
Advanced Materials (2022) Vol. 34, Iss. 24
Closed Access | Times Cited: 66
Nanoparticle-Based Approaches for Treatment of Hematological Malignancies: a Comprehensive Review
Umme Hani, B.H. Jaswanth Gowda, Nazima Haider, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 8
Closed Access | Times Cited: 38
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities
Ritwik Maiti, Bhumika Patel, Nrupesh Patel, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 5, pp. 361-388
Open Access | Times Cited: 26
Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review
Adilet Beishenaliev, Yean Leng Loke, Sook Jing Goh, et al.
Journal of Controlled Release (2023) Vol. 359, pp. 268-286
Closed Access | Times Cited: 24
Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy
Waqas Nawaz, Shijie Xu, Yanlei Li, et al.
Acta Biomaterialia (2020) Vol. 109, pp. 21-36
Open Access | Times Cited: 56
Nanomedicine strategies to target coronavirus
Marcel Alexander Heinrich, B Martina, Jai Prakash
Nano Today (2020) Vol. 35, pp. 100961-100961
Open Access | Times Cited: 55
Advances in antibody nanoconjugates for diagnosis and therapy: A review of recent studies and trends
Jamileh Kadkhoda, Mohammad Akrami-Hasan-Kohal, Mohammad Reza Tohidkia, et al.
International Journal of Biological Macromolecules (2021) Vol. 185, pp. 664-678
Closed Access | Times Cited: 55
Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer
Francisco J. Cimas, Enrique Niza, Alberto Juan, et al.
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 986-986
Open Access | Times Cited: 54
Microfluidics-assisted conjugation of chitosan-coated polymeric nanoparticles with antibodies: Significance in drug release, uptake, and cytotoxicity in breast cancer cells
Noé Escareño, Natalia Hassan, Marcelo J. Kogan, et al.
Journal of Colloid and Interface Science (2021) Vol. 591, pp. 440-450
Closed Access | Times Cited: 47
In silico SELEX screening and statistical analysis of newly designed 5mer peptide-aptamers as Bcl-xl inhibitors using the Taguchi method
Alireza Poustforoosh, Sanaz Faramarz, Mohammad Hadi Nematollahi, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105632-105632
Closed Access | Times Cited: 35
Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery
Phattalapol Lhaglham, Luksika Jiramonai, Yaru Jia, et al.
iScience (2024) Vol. 27, Iss. 11, pp. 111185-111185
Open Access | Times Cited: 6
Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma
Faheem Hyder Pottoo, Md. Abul Barkat, Harshita Abul Barkat, et al.
Seminars in Cancer Biology (2019) Vol. 69, pp. 100-108
Closed Access | Times Cited: 54
Page 1 - Next Page

Scroll to top